SCHEMBL26416271

SCHEMBL26416271

c1ccc(-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4c4ccc5ccccc5c43)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
TSPO P30536 1/20 0.38
HDAC4 P56524 1/20 0.38
PTGER4 P35408 1/20 0.36
NR3C1 P04150 1/20 0.36
KMT2A Q03164 2/20 0.35
IL1R1 P14778 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
PTGES O14684 1/20 0.34
NPY5R Q15761 1/20 0.33
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
DNM1 Q05193 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24765797 1.00 L3MBTL1 (0.47) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL24627338 1.00 L3MBTL1 (0.47) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17298652 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL10041762 0.95 NR3C1 (0.39) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL16405417 0.94 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL19829068 0.94 KDM4E (0.44) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL16405418 0.94 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL19933766 0.93 KDM4E (0.43) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL22186434 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMHDAC4PTGER4
SCHEMBL22186449 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMHDAC4PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 L3MBTL1 2788/4885KDM4E 3080/4885ATM 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.